Friday, March 24, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DHS Funds Further Development of Anthrax Diagnostic

by Global Biodefense Staff
January 5, 2015

The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has announced intentions to issue a new sole source contract to Omni Array Biotechnology for the continued development of its laboratory-based B. anthracis detection and diagnostic assays.

In the existing contract, Omni Array was selected to develop a rapid Anthrax diagnostics test and also a multiplex (Luminex-based) rapid Abrin detection test.

Omni Array is developing the novel multiplex Anthrax biomarker assay for clinical diagnostics testing and is at the completion stages of the rapid multiplex Abrin detection test. In addition to these efforts, Omni Array was also contracted to support DHS efforts in the validation of immunoassays to biothreat agents as a third party evaluation site.

The overall objective of the contracts is to develop and deploy novel and innovative rapid first responder, clinical diagnostic, and biothreat agent detection assays capable of fulfilling the needs of multiple agencies and departments by multiplexing assays to detect simultaneously select biothreat agents.

Source: FBO.gov

Tags: AbrinAnthraxBiomarkersBioterrorismPOC Diagnostics

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC